Abpro Holdings (ABPO) Treasury Shares (2022 - 2026)

Abpro Holdings' (ABPO) quarterly Treasury Shares came in at $33000.0 in Q4 2023.

Abpro Holdings (ABPO) Treasury Shares (2022 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 1 years of Treasury Shares data on file, last reported at $33000.0 in Q4 2023.

Quarterly Treasury Shares rose 174.75% year-over-year to $24503.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24503.0 (up 174.75% YoY) and the FY2025 annual result came in at $31169.0, up 195.09% from the prior year.
Treasury Shares eased to $24503.0 in Q1 2026, from $31169.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $30.0 million in Q1 2022 to a low of -$32778.0 in Q4 2024.
A 5-year average of $7.6 million and a median of $24503.0 in 2026 frame the typical range for Treasury Shares.
Annual changes were most pronounced in 2024 — Treasury Shares tumbled 367.86% — and 2025, when it soared 337.9%.
Tracing ABPO's Treasury Shares over 5 years: stood at $2.8 million in 2022, then slumped by 100.25% to -$7006.0 in 2023, then tumbled by 367.86% to -$32778.0 in 2024, then jumped by 195.09% to $31169.0 in 2025, then declined by 21.39% to $24503.0 in 2026.
The last three Treasury Shares figures came in at $24503.0 (Q1 2026), $31169.0 (Q4 2025), and $16667.0 (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	Abpro Holdings	1.14 Mn	1.14 Mn	-	-

Download Data